Literature DB >> 12534376

Elective resection and anastomosis for colorectal cancer: a prospective audit of mortality and morbidity 1976-1998.

Mark Killingback1, Prudence Barron, Owen Dent.   

Abstract

BACKGROUND: The purpose of this paper is to audit the morbidity and mortality for colorectal cancer after open elective resection and anastomosis by a single colorectal surgeon (MK), with reference to any differences between intraperitoneal (IPA) and extra-peritoneal anastomoses (EPA).
METHODS: The prospective documentation of postoperative complications was compiled by the surgeon, charge nurses and a research assistant (PB). The operations were performed in three hospitals between 1976 and 1998.
RESULTS: Some 1392 consecutive patients were treated electively by 1418 resections with anastomosis. There were 23 postoperative deaths (1.6%). Significant adverse events, which were potentially avoidable, occurred in 10 (43.5%) of the patients who died. The morbidity rate was 41.6%. Clinical anastomotic leaks occurred more frequently in EPA (27/581, 4.7%) than in IPA (2/827, 0.2%; P < 0.0001). Anastomotic leak caused the death of two patients (0.14%).Routine prophylactic anticoagulation did not decrease the incidence of pulmonary embolism. Significant thrombophlebitis at the intravenous cannula site occurred in 54 patients (3.8%), wound infection in 29 (2.1%), and postural peripheral nerve injury in the upper limbs occurred in 11 patients (0.8%). Thirty-eight patients (2.7%) were returned to the operating theatre for 42 unscheduled operations.
CONCLUSION: Mortality associated with elective resection of colorectal cancer with anastomosis is principally related to age, cardio-vascular disease and avoidable adverse events. A wide range of complications may follow this type of surgery, especially after extra peritoneal operations. A classification of anastomotic leaks is suggested to assist in comparisons of this complication which remains a significant concern following extra peritoneal anastomoses.

Entities:  

Mesh:

Year:  2002        PMID: 12534376     DOI: 10.1046/j.1445-2197.2002.02524.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

1.  Incidence, consequences, and risk factors for anastomotic dehiscence after colorectal surgery: a prospective monocentric study.

Authors:  Nicolas C Buchs; Pascal Gervaz; Michelle Secic; Pascal Bucher; Béatrice Mugnier-Konrad; Philippe Morel
Journal:  Int J Colorectal Dis       Date:  2007-11-22       Impact factor: 2.571

2.  Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer.

Authors:  B C Boer; F de Graaff; M Brusse-Keizer; D E Bouman; C H Slump; M Slee-Valentijn; J M Klaase
Journal:  Int J Colorectal Dis       Date:  2016-02-15       Impact factor: 2.571

3.  Complications following colon rectal surgery in the obese patient.

Authors:  Timothy M Geiger; Roberta Muldoon
Journal:  Clin Colon Rectal Surg       Date:  2011-12

4.  Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer.

Authors:  Martin Kruschewski; Hayo Rieger; Uwe Pohlen; Hubert G Hotz; Heinz J Buhr
Journal:  Int J Colorectal Dis       Date:  2007-01-27       Impact factor: 2.796

5.  Sarcopenia is associated with increased severe postoperative complications after colon cancer surgery.

Authors:  Tolga Olmez; Erdal Karakose; Hilmi Bozkurt; Halime Hanim Pence; Selcuk Gulmez; Emre Aray; Can Ibrahim Bulut; Ozlem Zeliha Sert; Erdal Polat; Mustafa Duman
Journal:  Arch Med Sci       Date:  2019-10-09       Impact factor: 3.318

6.  Potential hospital cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-audit.

Authors:  Louisa G Gordon; Andreas Obermair
Journal:  BMC Surg       Date:  2010-01-27       Impact factor: 2.102

Review 7.  Updates of Risk Factors for Anastomotic Leakage after Colorectal Surgery.

Authors:  Eugenia Claudia Zarnescu; Narcis Octavian Zarnescu; Radu Costea
Journal:  Diagnostics (Basel)       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.